J F Holland - Concepedia

Author

J F Holland

Icahn School of Medicine at Mount Sinai

Also Known As

Holland, J. F., Holland, James F., J F HOLLAND, J F Holland, J. F. Holland, J.F. Holland, James F. Holland, W Foo

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Memorial Sloan Kettering Cancer Center Roswell Park Comprehensive Cancer Center National Cancer Institute Mount Sinai Medical Center

About

J F Holland is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.3K
2	Health Sciences	10	10	390
3	Natural Sciences	2	2	127
4	Humanities	1	1	37
5	Anesthesia	1	1	15

J F Holland

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. Joseph Aisner, Vivian Weinberg, Michael Perloff, Journal of Clinical Oncology Breast OncologyAntibiotic AdjuvantImmunologyPharmacotherapyAntimicrobial Chemotherapy	1987	120
A phase I-II study of intensive-dose adriamycin for advanced breast cancer. Roy B. Jones, J F Holland, S. Bhardwaj, Journal of Clinical Oncology Advanced Breast CancerMetastatic Breast CancerBreast OncologyMedicineCancer Management	1987	119
Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Hiroyuki Kobayashi, Thambi Dorai, J F Holland, PubMed Molecular BiologyMultidrug-resistant Tumor CellsChemical BiologyTumor BiologyProtein Synthesis	1994	110
Inhibition of Invasion of Invasive Human Bladder Carcinoma Cells by Protein Kinase C Inhibitor Staurosporine Gary K. Schwartz, S. Mark Redwood, Takao Ohnuma, JNCI Journal of the National Cancer Institute UrologySignal TransductionProtein Kinase CGenitourinary CancerCell Signaling	1990	93
Psychological Symptoms and Disease-Free and Overall Survival in Women With Stage II Breast Cancer Susan Tross, J. Herndon, A. E. Korzun, JNCI Journal of the National Cancer Institute	1996	93
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Yasuhiko Kano, Takao Ohnuma, Teruo Okano, PubMed Simultaneous ExposureTumor BiologyHematological MalignancyMedicineMalignant Blood Disorder	1988	91
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. J. George Bekesi, G St-Arneault, J F Holland PubMed Leukemia L1210 ImmunogenicityProlonged IncubationPathogenesisImmunologyTherapeutic Efficacy	1971	80
Effect of age on therapeutic response and survival in advanced Hodgkin's disease. B. A. Peterson, Thomas F. Pajak, M. R. Cooper, PubMed AgingDisease ProgressionCancer ManagementImmunologyPathology	1982	73
The Variability of Individual Tolerance to Methotrexate in Cancer Patients H.H. Hansen, Oleg S. Selawry, J F Holland, British Journal of Cancer MedicineCancer ManagementPharmacologyBreast CancerPharmacotherapy	1971	68
Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion. Serge Leyvraz, T Ohnuma, M. Lassus, Journal of Clinical Oncology Cancer ManagementPharmacotherapyMyeloid NeoplasiaHematological MalignancyThrombosis	1985	61

Page 1